Psoriasis Is Accompanied by Low Serum Levels of MG-H1, GOLD and MOLD: LC-Orbitrap-MS/MS Analysis of Chosen Glycation Products.

Aleksandra Damasiewicz-Bodzek, Agnieszka Nowak, Maciej Maciejczyk, Magdalena Szumska, Sławomir Waligóra, Beata Pastuszka, Beata Janoszka

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aleksandra Damasiewicz-BodzekDepartment of Chemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0002-4400-1502

Agnieszka NowakDepartment of Chemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0002-1947-9299

Maciej MaciejczykDepartment of Chemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0002-0037-3232

Magdalena SzumskaDepartment of Chemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0003-0916-9972

Sławomir WaligóraDepartment of Chemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.

Beata PastuszkaResearch and Implementation Center Silesia LabMed, Medical University of Silesia, 40-752 Katowice, Poland.ORCID 0000-0001-8963-3549

Beata JanoszkaDepartment of Chemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0003-3017-0740

Funding

Medical University of Silesia BNW-1-055/K/4/O

6 · The paper itself

Abstract

Glycation is a type of post-translational protein modification that affects antigen self-recognition, cell signaling, the proteasomal degradation of proteins, protein solubility, and the mechanical properties of tissues. Some glycation products are able to cross-link proteins. Serum concentrations of the cross-linking GOLD (glyoxal lysine dimer) and MOLD (methylglyoxal lysine dimer), and the non-cross-linking MG-H1 (methylglyoxal-derived hydroimidazolone isomer 1) in patients with psoriasis (

Indexed as

Glycation End Products, AdvancedGoldImidazolesPsoriasisAdultChromatography, LiquidFemaleGlycosylationHumansLiquid Chromatography-Mass SpectrometryMaleMiddle AgedOrnithineTandem Mass SpectrometryGlycation End Products, AdvancedGoldImidazolesNdelta-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithineOrnithineAGEscross-linkingGOLDMG-H1MOLDpsoriasis

Identifiers

PMID42123846

DOI10.3390/molecules31091481

PMCPMC13165278

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.